Breast Cancer Vaccine Tests German Merck’s $1 Billion Strategy Thanks to Bloomberg coverage of Merck KGaa to make up for ONTY's I-know-nothing CEO - and who apparently did not even mention the STRIDE trial in BC to Adam F of theStreet.com when they spoke for that recent article. http://www.bloomberg.com/apps/news?pid=20601109&si d=aD2rO8iba81U&pos=14
Nov. 4 (Bloomberg) -- Merck KGaA of Germany is ...